-- Veritas In Silico（TKO：130A）と武田薬品工業（TKO：4502）は、mRNAを標的とした低分子医薬品に関する共同創薬研究を即時終了することで合意した。
2023年6月の合意開始以来、研究成果は一部得られているものの、両社は今後、共同研究で得られた知見の将来的な応用について協議・検討していくと、同日、東京証券取引所に提出した書類で明らかにした。
Veritas In Silico は、今回の合意終了による業績への影響は限定的であり、12月期決算の業績予想に変更はないと見込んでおり、重要な進展があれば速やかに開示するとしている。
Investors in a Blue Owl Capital (OWL) business development company tendered less than 1% of shares to Boaz Weinstein's Saba Capital Management and Cox Capital Partners, which had offered to buy them out at a significant discount, Bloomberg reported Monday, citing people familiar with the matter.Blue Owl didn't immediately reply to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $8.97, Change: $-0.21, Percent Change: -2.29%
First Bancorp (FBP) shares were up 3.4% in Monday trading after Raymond James upgraded the company's stock to strong buy from outperform and raised its price target to $27 from $26.Trading volume stood at about 537,000 shares, compared with a daily average of around 1.5 million.Price: $24.23, Change: $+0.82, Percent Change: +3.48%
Advanced Micro Devices (AMD) shares were down over 3% in Monday trading after Northland downgraded the company's stock to market perform from outperform.Trading volume stood at more than 38.6 million shares, compared with a daily average of around 38.2 million.Price: $335.90, Change: $-11.91, Percent Change: -3.42%